Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04215952 · ClinicalTrials.gov registry record · NA
Semantic Feature Analysis Treatment for Aphasia
A NA study of Aphasia, sponsored by VA Pittsburgh Healthcare System.
- Active
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT04215952: Active NA study of Aphasia, sponsored by VA Pittsburgh Healthcare System.
NCT04215952 is a NA study of Aphasia that is active but no longer recruiting, run by VA Pittsburgh Healthcare System. The registered enrollment target is 40 participants, below the 83-participant average among 42 other Aphasia trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04215952, a NA study of Aphasia, is active but no longer recruiting, sponsored by VA Pittsburgh Healthcare System.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This randomized controlled comparative effectiveness study examines manipulation of a key component of an established and efficacious treatment for naming impairments in aphasia, along with cognitive and brain correlates of treatment success. Study participants will be randomly assigned to one of two treatment conditions comparing two different versions of Semantic Feature Analysis treatment. Their performance on standardized and study-specific measures will be used to determine which version of the treatment provides superior outcomes, and measures of automatic language processing and functional brain imaging will also be used to identify the underlying neurocognitive mechanisms associated with positive treatment response.
Primary Outcome
Change in naming accuracy on 30 treated pictured object nouns and 30 untreated pictured object nouns semantically related to the treated items.
Conditions Studied
Interventions
- BEHAVIORAL Semantic Feature Analysis Treatment
Study Locations (1)
Pennsylvania
- VA Pittsburgh Healthcare System - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2020-02-24 |
| Est. Completion | 2025-08-30 |
| Phase | NA |
What the registry record for NCT04215952 still lists
NCT04215952 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 83-participant average among 42 other Aphasia trials with a reported enrollment target (52% lower).
The record links to 1 condition, with Aphasia appearing as the primary indexed condition, and to 1 intervention - of which Semantic Feature Analysis Treatment is the first listed.
NCT04215952 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04215952 about?
NCT04215952 is a clinical study titled "Semantic Feature Analysis Treatment for Aphasia". This randomized controlled comparative effectiveness study examines manipulation of a key component of an established and efficacious treatment for naming impairments in aphasia, along with cognitive and brain correlates of treatment success. Study participants will be randomly assigned to one of tw...
What is the current status of trial NCT04215952?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2020-02-24. Estimated completion is 2025-08-30.
What conditions does trial NCT04215952 study?
This clinical trial studies the following conditions: Aphasia.
What interventions are being tested in trial NCT04215952?
The interventions under investigation include: Semantic Feature Analysis Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT04215952?
This trial is sponsored by VA Pittsburgh Healthcare System, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04215952 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aphasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04215952's enrollment target sits among peer trials
40 30th of 42 higher than 12 of 42 other Aphasia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Aphasia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Transcranial Alternating Current Stimulation (tACS) in Aphasia
RECRUITING · NA
-
tACS to Enhance Language Abilities
RECRUITING · NA
-
Treatment Outcomes With tDCS in Post-Stroke Aphasia
RECRUITING · NA
-
Telerehabilitation for Aphasia (TERRA)
RECRUITING · NA
-
Combined Exercise and Targeted Therapy for Post-Stroke Reading Deficits
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI